nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Lorazepam—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Lorazepam—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Lorazepam—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Lorazepam—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Lorazepam—Pain—Topotecan—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Lorazepam—Constipation—Topotecan—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Lorazepam—Hepatocellular injury—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00116	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00116	CcSEcCtD
Lorazepam—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Lorazepam—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Lorazepam—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Lorazepam—Pain—Tretinoin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Lorazepam—Injection site reaction—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Lorazepam—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00114	0.00115	CcSEcCtD
Lorazepam—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Lorazepam—Coma—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Lorazepam—Pain—Melphalan—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Lorazepam—Bladder pain—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Lorazepam—Cystitis noninfective—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Lorazepam—Salivary hypersecretion—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Lorazepam—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Lorazepam—Cystitis—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00112	CcSEcCtD
Lorazepam—Pulmonary oedema—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Lorazepam—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Lorazepam—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Lorazepam—Agitation—Vincristine—peripheral nervous system neoplasm	0.0011	0.00111	CcSEcCtD
Lorazepam—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Lorazepam—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Lorazepam—Mental disability—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Lorazepam—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Lorazepam—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Lorazepam—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Lorazepam—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Lorazepam—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00107	0.00108	CcSEcCtD
Lorazepam—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Lorazepam—Coma—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00106	CcSEcCtD
Lorazepam—Bladder pain—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Lorazepam—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Lorazepam—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Lorazepam—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Lorazepam—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Lorazepam—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Lorazepam—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Lorazepam—Chills—Etoposide—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Lorazepam—Mental disability—Doxorubicin—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Lorazepam—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Lorazepam—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000997	0.000998	CcSEcCtD
Lorazepam—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000996	0.000997	CcSEcCtD
Lorazepam—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000995	0.000996	CcSEcCtD
Lorazepam—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000993	0.000994	CcSEcCtD
Lorazepam—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000989	0.00099	CcSEcCtD
Lorazepam—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000989	0.00099	CcSEcCtD
Lorazepam—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000988	0.000989	CcSEcCtD
Lorazepam—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000976	0.000977	CcSEcCtD
Lorazepam—Infection—Vincristine—peripheral nervous system neoplasm	0.000974	0.000975	CcSEcCtD
Lorazepam—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000971	0.000972	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Doxorubicin—peripheral nervous system neoplasm	0.000963	0.000965	CcSEcCtD
Lorazepam—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000963	0.000964	CcSEcCtD
Lorazepam—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000963	0.000964	CcSEcCtD
Lorazepam—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00096	0.000961	CcSEcCtD
Lorazepam—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000951	0.000952	CcSEcCtD
Lorazepam—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000951	0.000952	CcSEcCtD
Lorazepam—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000946	0.000947	CcSEcCtD
Lorazepam—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000938	0.000939	CcSEcCtD
Lorazepam—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000924	0.000925	CcSEcCtD
Lorazepam—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00092	0.000921	CcSEcCtD
Lorazepam—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000916	0.000917	CcSEcCtD
Lorazepam—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.000909	0.00091	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000906	0.000907	CcSEcCtD
Lorazepam—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.000906	0.000907	CcSEcCtD
Lorazepam—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000906	0.000907	CcSEcCtD
Lorazepam—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000904	0.000905	CcSEcCtD
Lorazepam—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000904	0.000905	CcSEcCtD
Lorazepam—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000895	0.000896	CcSEcCtD
Lorazepam—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000888	0.000889	CcSEcCtD
Lorazepam—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000888	0.000889	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000878	0.000879	CcSEcCtD
Lorazepam—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000877	0.000878	CcSEcCtD
Lorazepam—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000874	0.000875	CcSEcCtD
Lorazepam—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00087	0.000871	CcSEcCtD
Lorazepam—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00087	0.000871	CcSEcCtD
Lorazepam—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000861	0.000862	CcSEcCtD
Lorazepam—Infection—Cisplatin—peripheral nervous system neoplasm	0.000861	0.000862	CcSEcCtD
Lorazepam—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00086	0.000861	CcSEcCtD
Lorazepam—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000855	0.000856	CcSEcCtD
Lorazepam—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000853	0.000854	CcSEcCtD
Lorazepam—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000853	0.000854	CcSEcCtD
Lorazepam—Rash—Topotecan—peripheral nervous system neoplasm	0.000853	0.000854	CcSEcCtD
Lorazepam—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000852	0.000853	CcSEcCtD
Lorazepam—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000852	0.000853	CcSEcCtD
Lorazepam—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000849	0.00085	CcSEcCtD
Lorazepam—Headache—Topotecan—peripheral nervous system neoplasm	0.000848	0.000849	CcSEcCtD
Lorazepam—Rash—Tretinoin—peripheral nervous system neoplasm	0.000846	0.000847	CcSEcCtD
Lorazepam—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000846	0.000847	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000846	0.000847	CcSEcCtD
Lorazepam—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000846	0.000847	CcSEcCtD
Lorazepam—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000846	0.000847	CcSEcCtD
Lorazepam—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000846	0.000847	CcSEcCtD
Lorazepam—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000845	0.000846	CcSEcCtD
Lorazepam—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000843	0.000844	CcSEcCtD
Lorazepam—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000842	0.000843	CcSEcCtD
Lorazepam—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000841	0.000842	CcSEcCtD
Lorazepam—Headache—Tretinoin—peripheral nervous system neoplasm	0.000841	0.000842	CcSEcCtD
Lorazepam—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000841	0.000842	CcSEcCtD
Lorazepam—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00084	0.000841	CcSEcCtD
Lorazepam—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000838	0.000839	CcSEcCtD
Lorazepam—Constipation—Vincristine—peripheral nervous system neoplasm	0.000838	0.000839	CcSEcCtD
Lorazepam—Pain—Vincristine—peripheral nervous system neoplasm	0.000838	0.000839	CcSEcCtD
Lorazepam—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000838	0.000839	CcSEcCtD
Lorazepam—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000838	0.000839	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000838	0.000839	CcSEcCtD
Lorazepam—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000836	0.000837	CcSEcCtD
Lorazepam—Rash—Melphalan—peripheral nervous system neoplasm	0.000835	0.000836	CcSEcCtD
Lorazepam—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000835	0.000836	CcSEcCtD
Lorazepam—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00081	0.000811	CcSEcCtD
Lorazepam—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000808	0.000809	CcSEcCtD
Lorazepam—Nausea—Topotecan—peripheral nervous system neoplasm	0.000804	0.000805	CcSEcCtD
Lorazepam—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000801	0.000802	CcSEcCtD
Lorazepam—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000797	0.000798	CcSEcCtD
Lorazepam—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000797	0.000798	CcSEcCtD
Lorazepam—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000797	0.000798	CcSEcCtD
Lorazepam—Infection—Etoposide—peripheral nervous system neoplasm	0.000789	0.00079	CcSEcCtD
Lorazepam—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000788	0.000789	CcSEcCtD
Lorazepam—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000787	0.000788	CcSEcCtD
Lorazepam—Nausea—Melphalan—peripheral nervous system neoplasm	0.000787	0.000788	CcSEcCtD
Lorazepam—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000777	0.000778	CcSEcCtD
Lorazepam—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000775	0.000776	CcSEcCtD
Lorazepam—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000774	0.000775	CcSEcCtD
Lorazepam—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000749	0.00075	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000748	0.000749	CcSEcCtD
Lorazepam—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000743	0.000744	CcSEcCtD
Lorazepam—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000742	0.000743	CcSEcCtD
Lorazepam—Pain—Cisplatin—peripheral nervous system neoplasm	0.000741	0.000742	CcSEcCtD
Lorazepam—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00073	0.000731	CcSEcCtD
Lorazepam—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000722	0.000723	CcSEcCtD
Lorazepam—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000714	0.000715	CcSEcCtD
Lorazepam—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000706	0.000707	CcSEcCtD
Lorazepam—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000703	0.000704	CcSEcCtD
Lorazepam—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000698	0.000699	CcSEcCtD
Lorazepam—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000698	0.000698	CcSEcCtD
Lorazepam—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000692	0.000693	CcSEcCtD
Lorazepam—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000688	0.000689	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000686	0.000686	CcSEcCtD
Lorazepam—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000685	0.000685	CcSEcCtD
Lorazepam—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00068	0.000681	CcSEcCtD
Lorazepam—Pain—Etoposide—peripheral nervous system neoplasm	0.000679	0.00068	CcSEcCtD
Lorazepam—Constipation—Etoposide—peripheral nervous system neoplasm	0.000679	0.00068	CcSEcCtD
Lorazepam—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000673	0.000674	CcSEcCtD
Lorazepam—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000654	0.000655	CcSEcCtD
Lorazepam—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000652	0.000652	CcSEcCtD
Lorazepam—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000651	0.000652	CcSEcCtD
Lorazepam—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000648	0.000649	CcSEcCtD
Lorazepam—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000647	0.000648	CcSEcCtD
Lorazepam—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000646	0.000647	CcSEcCtD
Lorazepam—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000641	0.000642	CcSEcCtD
Lorazepam—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000641	0.000642	CcSEcCtD
Lorazepam—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000639	0.000639	CcSEcCtD
Lorazepam—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000638	0.000639	CcSEcCtD
Lorazepam—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000637	0.000638	CcSEcCtD
Lorazepam—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000629	0.00063	CcSEcCtD
Lorazepam—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000623	0.000624	CcSEcCtD
Lorazepam—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000622	0.000623	CcSEcCtD
Lorazepam—Rash—Vincristine—peripheral nervous system neoplasm	0.000618	0.000619	CcSEcCtD
Lorazepam—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000617	0.000618	CcSEcCtD
Lorazepam—Headache—Vincristine—peripheral nervous system neoplasm	0.000614	0.000615	CcSEcCtD
Lorazepam—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000604	0.000605	CcSEcCtD
Lorazepam—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000604	0.000604	CcSEcCtD
Lorazepam—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000603	0.000603	CcSEcCtD
Lorazepam—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00059	0.000591	CcSEcCtD
Lorazepam—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000585	0.000586	CcSEcCtD
Lorazepam—Nausea—Vincristine—peripheral nervous system neoplasm	0.000582	0.000583	CcSEcCtD
Lorazepam—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00057	0.00057	CcSEcCtD
Lorazepam—Chills—Epirubicin—peripheral nervous system neoplasm	0.000562	0.000563	CcSEcCtD
Lorazepam—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00056	0.00056	CcSEcCtD
Lorazepam—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000559	0.000559	CcSEcCtD
Lorazepam—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000554	0.000554	CcSEcCtD
Lorazepam—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000551	0.000552	CcSEcCtD
Lorazepam—Rash—Cisplatin—peripheral nervous system neoplasm	0.000546	0.000547	CcSEcCtD
Lorazepam—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000546	0.000547	CcSEcCtD
Lorazepam—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000545	0.000546	CcSEcCtD
Lorazepam—Tension—Epirubicin—peripheral nervous system neoplasm	0.000535	0.000536	CcSEcCtD
Lorazepam—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00053	0.00053	CcSEcCtD
Lorazepam—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000525	0.000526	CcSEcCtD
Lorazepam—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.000521	CcSEcCtD
Lorazepam—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000518	0.000518	CcSEcCtD
Lorazepam—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000515	0.000515	CcSEcCtD
Lorazepam—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000514	0.000515	CcSEcCtD
Lorazepam—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000512	0.000513	CcSEcCtD
Lorazepam—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000505	0.000505	CcSEcCtD
Lorazepam—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000505	0.000505	CcSEcCtD
Lorazepam—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000501	0.000502	CcSEcCtD
Lorazepam—Rash—Etoposide—peripheral nervous system neoplasm	0.000501	0.000501	CcSEcCtD
Lorazepam—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.0005	0.000501	CcSEcCtD
Lorazepam—Headache—Etoposide—peripheral nervous system neoplasm	0.000497	0.000498	CcSEcCtD
Lorazepam—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.000496	CcSEcCtD
Lorazepam—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00049	0.000491	CcSEcCtD
Lorazepam—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00049	0.000491	CcSEcCtD
Lorazepam—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.000476	CcSEcCtD
Lorazepam—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000473	0.000473	CcSEcCtD
Lorazepam—Nausea—Etoposide—peripheral nervous system neoplasm	0.000472	0.000472	CcSEcCtD
Lorazepam—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000471	0.000471	CcSEcCtD
Lorazepam—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000464	CcSEcCtD
Lorazepam—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000454	0.000455	CcSEcCtD
Lorazepam—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.000454	CcSEcCtD
Lorazepam—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000449	0.000449	CcSEcCtD
Lorazepam—Infection—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000443	CcSEcCtD
Lorazepam—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000437	0.000438	CcSEcCtD
Lorazepam—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Lorazepam—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Lorazepam—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000434	0.000435	CcSEcCtD
Lorazepam—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.000421	CcSEcCtD
Lorazepam—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000416	0.000416	CcSEcCtD
Lorazepam—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000416	CcSEcCtD
Lorazepam—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.00041	CcSEcCtD
Lorazepam—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000404	CcSEcCtD
Lorazepam—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000402	0.000402	CcSEcCtD
Lorazepam—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000396	0.000396	CcSEcCtD
Lorazepam—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.000385	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000384	0.000385	CcSEcCtD
Lorazepam—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000384	0.000384	CcSEcCtD
Lorazepam—Pain—Epirubicin—peripheral nervous system neoplasm	0.000381	0.000381	CcSEcCtD
Lorazepam—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000381	0.000381	CcSEcCtD
Lorazepam—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000367	0.000367	CcSEcCtD
Lorazepam—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.000367	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.000356	CcSEcCtD
Lorazepam—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000356	CcSEcCtD
Lorazepam—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000353	CcSEcCtD
Lorazepam—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000353	CcSEcCtD
Lorazepam—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.00034	CcSEcCtD
Lorazepam—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000328	CcSEcCtD
Lorazepam—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000319	0.00032	CcSEcCtD
Lorazepam—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000304	CcSEcCtD
Lorazepam—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000296	CcSEcCtD
Lorazepam—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000295	CcSEcCtD
Lorazepam—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000283	CcSEcCtD
Lorazepam—Rash—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000281	CcSEcCtD
Lorazepam—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000281	CcSEcCtD
Lorazepam—Headache—Epirubicin—peripheral nervous system neoplasm	0.000279	0.000279	CcSEcCtD
Lorazepam—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000273	CcSEcCtD
Lorazepam—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000265	CcSEcCtD
Lorazepam—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000262	CcSEcCtD
Lorazepam—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.00026	CcSEcCtD
Lorazepam—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.00026	CcSEcCtD
Lorazepam—Diclofenac—ABCB1—peripheral nervous system neoplasm	0.000258	0.207	CrCbGaD
Lorazepam—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000258	CcSEcCtD
Lorazepam—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000245	CcSEcCtD
Lorazepam—Nitrazepam—ABCB1—peripheral nervous system neoplasm	0.000195	0.156	CrCbGaD
Lorazepam—Chlorprothixene—ABCB1—peripheral nervous system neoplasm	0.000186	0.149	CrCbGaD
Lorazepam—Flurazepam—ABCB1—peripheral nervous system neoplasm	0.000174	0.139	CrCbGaD
Lorazepam—Midazolam—ABCB1—peripheral nervous system neoplasm	0.000161	0.129	CrCbGaD
Lorazepam—Diazepam—ABCB1—peripheral nervous system neoplasm	0.000138	0.11	CrCbGaD
Lorazepam—Clozapine—ABCB1—peripheral nervous system neoplasm	0.000136	0.109	CrCbGaD
